Document is current
Any future updates will be listed below
-
Authors
Rathod, Shardul N.
Ropski, Pamela
Glowala, Jakub
Quinn, Charles M.
Stamper, Alyssa
Bolon, Maureen K.
Schimmel, Daniel
Chiu, Stephen F.
Malaisrie, S. Chris C.
Cuttica, Mike J.
Mylvaganam, Ruben https://orcid.org/0000-0002-7203-7609
- License Information
-
More Information
Article History
Received: 26 August 2024
Accepted: 27 February 2025
First Online: 14 March 2025
Declarations
:
: This study received approval from the Northwestern University Institutional Review Board (IRB) STU00009959. All patients provided informed written consent for the presentation and publication of their study data, adhering to ethical standards in accordance with the Declaration of Helsinki.
: As this study involved standard clinical procedures and assessments without an experimental treatment protocol, it did not require registration with a public clinical trials registry.
: The authors declare the following financial interests/personal relationships which may be considered as potential competing interests: Ruben Mylvaganam reports a relationship with United Therapeutics Corporation Research and Development that includes: consulting or advisory. Michael Cuttica reports a relationship with United Therapeutics Corporation Research and Development that includes: consulting or advisory. Michael Cuttica reports a relationship with Janssen Pharmaceuticals Inc that includes: consulting or advisory. Michael Cuttica reports a relationship with Bayer Corporation that includes: consulting or advisory. Michael Cuttica reports a relationship with Insemd that includes: funding grants. Ruben Mylvaganam reports a relationship with Janssen Pharmaceuticals Inc that includes: funding grants. Daniel Schimmel reports a relationship with Penumbra Inc that includes: consulting or advisory, funding grants, and speaking and lecture fees. Daniel Schimmel reports a relationship with Inari Medical Inc that includes: consulting or advisory, funding grants, and speaking and lecture fees. Daniel Schimmel reports a relationship with Sanofi-Aventis US LLC that includes: funding grants. Daniel Schimmel reports a relationship with Boston Scientific Corp that includes: consulting or advisory and funding grants. If there are other authors, they declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. The authors received no funding for this study. The authors declare that they have no financial interests or relationships that could be perceived as a conflict of interest regarding the publication of this manuscript.
